首页> 外文期刊>Frontiers in Neuropharmacology >Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study
【24h】

Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study

机译:可卡因患者的长期结果使用障碍:18年的成瘾队列研究

获取原文
       

摘要

Cocaine Use Disorder (CUD) has been associated with multiple complications and premature death. The purpose of the present study was to analyze the relationship between baseline medical comorbidity and long-term medical outcomes (i.e., hospitalization, death) in a cohort of patients primarily admitted for detoxification. In addition, we aimed to analyze cause-specific mortality. Methods: longitudinal study in CUD patients admitted for detoxification between 2001 and 2018. Substance use characteristics, laboratory parameters and medical comorbidity by VACS Index were assessed at admission. Follow-up and health-related outcomes were ascertained through visits and e-health records. Kaplan-Meier and Cox regression models were used to analyze survival and predictors of hospitalization and death. Results: 175 patients (77.7% men) were included. Age at admission was 35 years [IQR: 30–41 years], 59.4% of the patients being intranasal users, 33.5% injectors, and 7.1% smokers. Almost 23% of patients had concomitant alcohol use disorder, 39% were cannabis users and 9% opiate users. The median VACS Index score on admission was 10 points [IQR: 0–22]. After 12 years [IQR: 8.6–15 years] of follow-up there were 1,292 (80.7%) ED admissions and 308 (19.3%) hospitalizations. The incidence rate of ED admission and hospitalization was 18.6 × 100 p-y (95% CI: 15.8–21.8 × 100 p-y). Mortality rate was 1.4 × 100 p-y (95% CI: 0.9–2.0 × 100 p-y) and, baseline comorbidity predicted hospitalization and mortality: those with VACS Index >40 were 3.5 times (HR:3.52, 95% CI: 1.19–10.4) more likely to dye with respect to patients with VACS < 20. Conclusion: addiction care warrants optimal stratification of medical comorbidity to improve health outcomes and survival of CUD patients seeking treatment of the disorder.
机译:可卡因使用障碍(CUD)与多重并发症有关,死亡过早。本研究的目的是分析基线医疗合并和长期医学结果(即住院,死亡)之间的关系,主要录取排毒的患者。此外,我们旨在分析原因特异性死亡率。方法:在2001年至2018年期间入院患者的纵向研究。在入院时评估了VAC的物质使用特征,实验室参数和医疗合并症。通过访问和电子健康记录确定了随访和健康的结果。 Kaplan-Meier和Cox回归模型用于分析住院和死亡的生存和预测。结果:175名患者(77.7%)。入学年龄是35年[IQR:30-41岁],59.4%的患者是鼻内用户,33.5%的注射器,7.1%吸烟者。近23%的患者伴随着酒精使用障碍,39%是大麻用户和9%的鸦片用户。入学中的中位VAC指数分数为10分[IQR:0-22]。 12年后[IQR:8.6-15岁以后的后续行动有1,292名(80.7%)宴入院和308(19.3%)住院。 ED入院和住院的发病率为18.6×100p-Y(95%CI:15.8-21.8×100p-y)。死亡率为1.4×100 pY(95%CI:0.9-2.0×100 py),基线合并症预测住院治疗和死亡率:VACS指数> 40的人数为3.5倍(HR:3.52,95%CI:1.19-10.4)更有可能染色患者<20.结论:成瘾保证认证有效地分层治疗医疗合并症,以改善寻求治疗疾病治疗的患者的健康结果和存活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号